But Medicaid coverage for obesity treatment has been extremely limited, in part because of the cost of the drugs
While emerging research explores potential anti-inflammatory properties of GLP-1 receptor agonists, tirzepatide has no FDA approval for autoimmune conditions such as rheumatoid arthritis, lupus, or inflammatory bowel disease
Caution is advised in patients with a history of pancreatitis or severe gastrointestinal disease
Oral semaglutide does not affect the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel
Semaglutide Tablet Starter Dose : Start Semaglutide with 3 mg once daily for 30 days Maintenance Dose : After 30 days on the 3 mg dose, increase the dose to 7 mg once daily For Additional Glycemic Control : If additional glycemic control is needed after at least 30 days on the 7 mg dose, the dose can be increased to 14 mg once daily Semaglutide injection : The starting dose is 0.25 mg Semaglutide once weekly
If you are taking other weight loss medications or specific medications that may interact with semaglutide, get medical advice to avoid any adverse effects
